News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Podlesak Dennis
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/16/2022 |
4
| Podlesak Dennis (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc
Txns:
| Sold 66,840 shares
@ $24.1978, valued at
$1.6M
Sold 5,419 shares
@ $23.4327, valued at
$127k
Sold 6,556 shares
@ $23.4327, valued at
$153.6k
Exercised 66,840 options to buy
@ $6.32, valued at
$422.4k
Exercised 6,556 options to buy
@ $6.35, valued at
$41.6k
Exercised 5,419 options to buy
@ $6.32, valued at
$34.2k
|
|
02/03/2022 |
4
| Podlesak Dennis (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc
Txns:
| Granted 32,000 shares
@ $0 |
|
10/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/14/2020 |
4
| Podlesak Dennis (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc
Txns:
| Granted 44,000 options to buy
@ $9.47, valued at
$416.7k
|
|
06/12/2019 |
4
| Podlesak Dennis (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc
Txns:
| Granted 44,000 options to buy
@ $7.88, valued at
$346.7k
|
|
05/07/2019 |
4
| Podlesak Dennis (Director) has filed a Form 4 on Alliqua BioMedical, Inc.
Txns:
| Granted 85,254 shares
@ $0 Granted 396 options to buy
@ $1.39, valued at
$550.4 Granted 55,879 options to buy
@ $3.06, valued at
$171k
|
|
05/25/2018 |
4
| Podlesak Dennis (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc
Txns:
| Granted 14,000 options to buy
@ $8.93, valued at
$125k
|
|
02/12/2018 |
4
| Podlesak Dennis (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc
Txns:
| Granted 10,000 options to buy
@ $9.63, valued at
$96.3k
|
|
05/19/2017 |
4
| Podlesak Dennis (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc
Txns:
| Granted 10,000 options to buy
@ $13.58, valued at
$135.8k
Granted 5,000 options to buy
@ $13.58, valued at
$67.9k
|
|
11/03/2016 |
4
| Podlesak Dennis (Director) has filed a Form 4 on Tobira Therapeutics, Inc.
Txns:
| Disposed/sold 232 options to buy
@ $112.77, valued at
$26.2k
Disposed/sold 9,314 options to buy
@ $112.77, valued at
$1.1M
Disposed/sold 232 options to buy
@ $105.21, valued at
$24.4k
Disposed/sold 10,253 options to buy
@ $40.59, valued at
$416.2k
Disposed/sold 40,733 options to buy
@ $36, valued at
$1.5M
Disposed/sold 1,071 options to buy
@ $42.93, valued at
$46k
Disposed/sold 27,500 options to buy
@ $16.52, valued at
$454.3k
Disposed/sold 53,334 options to buy
@ $7.91, valued at
$421.9k
Disposed/sold 2,947 options to buy
@ $34.56, valued at
$101.8k
Disposed/sold 17,695 options to buy
@ $8.19, valued at
$144.9k
|
|
11/02/2016 |
4
| Podlesak Dennis (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc |
01/14/2016 |
4
| Podlesak Dennis (Director) has filed a Form 4 on Tobira Therapeutics, Inc.
Txns:
| Granted 53,334 options to buy
@ $7.91, valued at
$421.9k
|
|
07/13/2015 |
4
| Podlesak Dennis (Director) has filed a Form 4 on Tobira Therapeutics, Inc.
Txns:
| Granted 27,500 options to buy
@ $16.52, valued at
$454.3k
|
|
01/05/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/14/2014 |
4
| Podlesak Dennis (Director) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.
Txns:
| Granted 28,900 shares
@ $0 |
|
01/03/2014 |
4
| Podlesak Dennis (Director) has filed a Form 4 on Regado Biosciences Inc
Txns:
| Granted 9,640 options to buy
@ $4.77, valued at
$46k
|
|
08/29/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/19/2013 |
4
| Podlesak Dennis (Director) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.
Txns:
| Granted 38,900 shares
@ $0 |
|
02/17/2012 |
4
| Podlesak Dennis (Director) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.
Txns:
| Granted 30,000 shares
@ $0 |
|
02/10/2011 |
4
| Podlesak Dennis (Director) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.
Txns:
| Granted 30,000 shares
@ $0 |
|
02/22/2010 |
4
| Podlesak Dennis (Director) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.
Txns:
| Granted 40,000 shares
@ $0 |
|
02/20/2009 |
4
| Podlesak Dennis (Director) has filed a Form 4 on AVANIR PHARMACEUTICALS |
|
|